Taiwan has signed a second contract with American drugmaker Pfizer to procure 350,000 courses of their COVID-19 treatment medicine Paxlovid, which will arrive by the end of June, Minister of Health and Welfare Chen Shih-chung (陳時中) said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
PLA exercises send messages to Taiwan, Japan, U.S.: Experts
12/29/2025 06:21 PM - Culture
'Culture Points' cash to be available for 13-22-year-olds in 2026
12/29/2025 06:08 PM - Politics
DPP, KMT trade blame over China policy as PRC drills draw condemnation
12/29/2025 05:26 PM - Business
Taiwan shares end up as TSMC hits record high
12/29/2025 04:32 PM - Business
U.S. dollar closes lower on Taipei forex market
12/29/2025 04:13 PM